~~<i id='2861831906'><strike id='2861831906'><tt id='2861831906'><pre id='2861831906'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

explore

author：explore 2025-09-30 00:09:36 - browse：37142

A sign of AdventHealth on its building in Orlando, Florida — coverage from STAT — Adobe

A lawsuit between a large hospital system and a dominant vendor that works for health insurance companies is getting a lot more heated — with one party calling the other an “economic parasite.”

The suit, between nonprofit hospital giant AdventHealth and MultiPlan, is now even attracting rare interest from the nation’s biggest hospital lobbyists.

The new, highly detailed legal filings also come right as MultiPlan and more than a dozen of the largest tax-exempt, nonprofit hospital systems are wooing investors at the J.P. Morgan Healthcare Conference. AdventHealth did not attend this year’s conference, but did so last year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Doctors have an ethical obligation to be advocates

hotspot

focus

Wikipedia

entertainment

explore

knowledge

CHICAGO--Sixpeoplehavediedandatleast20otherswerewoundedinweekendshootingsacrossChicago.Ashootingearl

WSS

Argenx readies a blockbuster opportunity with drug for autoimmune disease

My chronic pain journey would have been easier knowing 5 things % STAT

AstraZeneca to buy developer of next

App could help diagnose ear infections more accurately — and at home

Methadone treatment changes are coming. Do they go far enough?

FDA approves first blood sugar monitor without finger pricks

hotspot

explore

hotspot

In Memoriam: Notable people who died in 2023

Novartis develops a rapidly manufactured CAR

At least 13 dead in Texas as scorching temps continue

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Novavax promises a turnaround & Lilly roils the obesity market

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Medical records are filled with copy

FDA approves first blood sugar monitor without finger pricks

Walensky prepares to leave CDC — and Congress — behind

Creating egg and sperm cells from stem cells raises ethical issues

focus

Colonoscopy prep: Liquid

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

FAMU bans football players from facility after release of rap video shot in team's locker room

4 missing after record

Intermittent fasting comes with a heart risk? Not so fast

Wikipedia

entertainment

explore

knowledge